Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-01

Clinical Trial Update: Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of irbesartan/hydrochlorothiazide completed, evaluating treatment for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVALIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED